Formulation and characterization of organic- inorganic hybrid film for transdermal drug delivery
Keywords:Meloxicam, Organic–inorganic hybrid gel, Bioadhesion, Transdermal drug delivery
A novel organic–inorganic hybrid film-forming gel for transdermal application was developed by poly vinyl alcohol using Di methyl polysiloxane as an inorganic-modifying agent, poly N-vinyl pyrrolidone as a tackifier and PEG 200 as a plasticizer. The hybrid film-forming gel can be directly applied on the skin forms a thin bioadhesive film with transparent and non- greasy feeling. The mechanical and bioadhesive properties of films produced from the hybrid gels were investigated and the results showed that the incorporation of appropriate Di methyl polysiloxane into the PVA matrix significantly improves the mechanical strength and skin adhesion properties of the resulting film. In conclusion, the bioadhesive films formed from organic–inorganic hybrid gel holds excellent qualities for application on the skin and may provide a promising formulation for transdermal delivery of drugs, especially when the patient acceptability from an aesthetic perspective of the dosage form is a main consideration.
Langer R, Transdermal drug delivery: past progress, current status and future prospects. Adv. Drug Dev. Rev. 2004; 56: 557–558.
Alberti I, Grenier A, Kraus H, Carrara DN. Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery. Expert Opin. Drug Deliv. 2005; 2(5): 935–950.
Aktar B, Erdal M, Sagirli O, Gungor S, Ozsoy Y. Optimization of biopolymer based transdermal films of metoclopramide as an alternative delivery approach. Polymers. 2014; 6(5): 1350–1365
Kumar V , Zakir F, Agarwal G, Choudhary A. Formulation and evaluation of buccal patches of venlafaxine. Inter J of Pharmy and Bio Sci. 2011; 1(3): 170–182
Shakhtshneider TP, Myz SA, Dyakonova MA, Boldyrev VA, Boldyreva EV, Nizovskiic AI, Kalinkinc AV, Kumar R. Mechanochemical preparation of organic-inorganic hybrid materials of drugs with inorganic oxides. Acta Physica Polonica A. 2011; 120: 272-278
Bae BS, Choi YK, Eo YJ, Park OH. Inorganic organic co polymer using Polyvinyl alcohol silane coupling agent and preparation thereof. US patent. US 6,337,370 B12002
Seal BL, Otero OL, Panitch A. Polymeric biomaterials for tissue and organ regeneration. Mater. Sci. Eng. 2001; 34: 147–230.
Juntanon K, Niamlang S, Rujiravanit R, Sirivat A. Electrically controlled release of sulfosalicylic acid from crosslinked poly(vinyl alcohol) hydrogel, Int. J. Pharm. 2008; 356: 1–11
Burke A, Smyth E, FitzGerald GA. Analgesic-anti pyretic and anti inflammatory agents; pharmacotherapy of gout. In: Bruntom LL, Lazo JS, Parker KL, editors. Goodman's and Gilman's the pharmacological basis of therapeutics. New York: McGraw Hill; 2006. pp. 676–700
Villegas I, Alarcon de la Lastra C, La Casa C, Motilva V, Martın MJ. Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats. Eur J Pharmacol. 2001; 414: 79–86.
Peng FB, Lu LY, Sun HL, Jiang ZY. Analysis of annealing effect on pervaporation properties of PVA–GPTMS hybrid membranes through PALS. J. Membr. Sci. 2006; 281: 600–608
Guo R, Du X, Zhang R, Deng L, Dong A, Zhang J. Bioadhesive film formed from a novel organic-inorganic hybrid gel for transdermal drug delivery system. Eur J Pharm Biopharm. 2011;79(3): 574-83.
Yong CS, Choi JS, Quan QZ, Rhee JD, Kim CK, Lim SJ, et.al. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int. J Pharm 2001; 226: 195–205.
Mitra J, mohammad RR Hedayte S. Mucoadhesive and Drug Release Properties of Benzocaine Gel. Iranian J Pharm sci. 2006; 2 :185-94.
Thomas BJ. Finnin BC. The transdermal revolution, Drug Discov Today. 2004; 9 (16): 697–703.
Kim JH, Choi HK . Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. Int. J. Pharm. 2002; 236: 81–85.
How to Cite
Copyright (c) 2020 J B Taksande, Mona Gupta, R V Trivedi, K J Wadher, M J Umekar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
In submitting an article to Journal of Applied Pharmaceutical Research (JOAPR) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JOAPR are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution-NonCommercial 4.0 International License
- I, and all co-authors, agree that, if the article is editorially accepted for publication in Journal of Applied Pharmaceutical Research (JOAPR) data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.